Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

May 1, 1996; Volume 156,Issue 9

CUTTING EDGE

  • You have accessRestricted access
    Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation.
    T A Bennett, E B Lynam, L A Sklar and S Rogelj
    J Immunol May 1, 1996, 156 (9) 3093-3097;
  • You have accessRestricted access
    A human killer inhibitory receptor specific for HLA-A1,2.
    C Döhring, D Scheidegger, J Samaridis, M Cella and M Colonna
    J Immunol May 1, 1996, 156 (9) 3098-3101;
  • You have accessRestricted access
    Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family.
    M Mohamadzadeh, A N Poltorak, P R Bergstressor, B Beutler and A Takashima
    J Immunol May 1, 1996, 156 (9) 3102-3106;
  • You have accessRestricted access
    Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes.
    C A Salkowski, S A Barber, G R Detore and S N Vogel
    J Immunol May 1, 1996, 156 (9) 3107-3110;

ARTICLES

  • You have accessRestricted access
    Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph.
    M A Abitorabi, C R Mackay, E H Jerome, O Osorio, E C Butcher and D J Erle
    J Immunol May 1, 1996, 156 (9) 3111-3117;
  • You have accessRestricted access
    Ligation of CD40 influences the function of human Ig-secreting B cell hybridomas both positively and negatively.
    M C Bergman, J F Attrep, A C Grammer and P E Lipsky
    J Immunol May 1, 1996, 156 (9) 3118-3132;
  • You have accessRestricted access
    Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis.
    M H Blotta, J D Marshall, R H DeKruyff and D T Umetsu
    J Immunol May 1, 1996, 156 (9) 3133-3140;
  • You have accessRestricted access
    A role for c-myc in the regulation of thymocyte differentiation and possibly positive selection.
    C Broussard-Diehl, S R Bauer and R H Scheuermann
    J Immunol May 1, 1996, 156 (9) 3141-3150;
  • You have accessRestricted access
    Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein.
    M L Disis, J R Gralow, H Bernhard, S L Hand, W D Rubin and M A Cheever
    J Immunol May 1, 1996, 156 (9) 3151-3158;
  • You have accessRestricted access
    IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells.
    P Jeannin, Y Delneste, M Seveso, P Life and J Y Bonnefoy
    J Immunol May 1, 1996, 156 (9) 3159-3165;
  • You have accessRestricted access
    Continuous administration of Il-13 to mice induces extramedullary hemopoiesis and monocytosis.
    Y H Lai, J M Heslan, S Poppema, J F Elliott and T R Mosmann
    J Immunol May 1, 1996, 156 (9) 3166-3173;
  • You have accessRestricted access
    Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha.
    W Min, J S Pober and D R Johnson
    J Immunol May 1, 1996, 156 (9) 3174-3183;
  • You have accessRestricted access
    CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation.
    B Mollereau, M Deckert, O Déas, F Rieux-Laucat, F Hirsch, A Bernard, A Fischer, D H Lynch, B Charpentier, F Le Deist and A Senik
    J Immunol May 1, 1996, 156 (9) 3184-3190;
  • You have accessRestricted access
    HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens: identification of antigenic epitopes.
    T Neeno, C J Krco, J Harders, J Baisch, S Cheng and C S David
    J Immunol May 1, 1996, 156 (9) 3191-3195;
  • You have accessRestricted access
    Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing.
    A Neisig, R Wubbolts, X Zang, C Melief and J Neefjes
    J Immunol May 1, 1996, 156 (9) 3196-3206;
  • You have accessRestricted access
    In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells.
    M Osawa, K Nakamura, N Nishi, N Takahasi, Y Tokuomoto, H Inoue and H Nakauchi
    J Immunol May 1, 1996, 156 (9) 3207-3214;
  • You have accessRestricted access
    Proteolytic cleavage of alpha-actinin by calpain in T cells stimulated with anti-CD3 monoclonal antibody.
    N Selliah, W H Brooks and T L Roszman
    J Immunol May 1, 1996, 156 (9) 3215-3221;
  • You have accessRestricted access
    CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
    J M Teng, X R Liu, G B Mills and B Dupont
    J Immunol May 1, 1996, 156 (9) 3222-3232;
  • You have accessRestricted access
    Il-7 supports D-J but not V-DJ rearrangement of TCR-beta gene in fetal liver progenitor cells.
    S Tsuda, S Rieke, Y Hashimoto, H Nakauchi and Y Takahama
    J Immunol May 1, 1996, 156 (9) 3233-3242;
  • You have accessRestricted access
    Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.
    H Y Wang, Z Xin, H Tang and D Ganea
    J Immunol May 1, 1996, 156 (9) 3243-3253;
  • You have accessRestricted access
    Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells.
    H S Warren, B F Kinnear, R L Kastelein and L L Lanier
    J Immunol May 1, 1996, 156 (9) 3254-3259;
  • You have accessRestricted access
    Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation.
    Z Yao, E Maraskovsky, M K Spriggs, J I Cohen, R J Armitage and M R Alderson
    J Immunol May 1, 1996, 156 (9) 3260-3266;
  • You have accessRestricted access
    Enhanced development of Th2-like primary CD4 effectors in response to sustained exposure to limited rIL-4 in vivo.
    K Yoshimoto, S L Swain and L M Bradley
    J Immunol May 1, 1996, 156 (9) 3267-3274;
  • You have accessRestricted access
    Unusual uniformity of the N-linked oligosaccharides of HLA-A, -B, and -C glycoproteins.
    L D Barber, T P Patel, L Percival, J E Gumperz, L L Lanier, J H Phillips, J C Bigge, M R Wormwald, R B Parekh and P Parham
    J Immunol May 1, 1996, 156 (9) 3275-3284;
  • You have accessRestricted access
    Tolerance of single, but not multiple, amino acid replacements in antibody VH CDR 2: a means of minimizing B cell wastage from somatic hypermutation?
    M Brown, M B Rittenburg, C Chen and V A Roberts
    J Immunol May 1, 1996, 156 (9) 3285-3291;
  • You have accessRestricted access
    Expression and characterization of functionally active recombinant perforin produced in insect cells.
    C C Liu, P M Persechini and J D Young
    J Immunol May 1, 1996, 156 (9) 3292-3300;
  • You have accessRestricted access
    The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3.
    M C Morse, G Bleau, V M Dabhi, F Hétu, E A Drobetsky, K F Lindahl and C Perreault
    J Immunol May 1, 1996, 156 (9) 3301-3307;
  • You have accessRestricted access
    Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.
    S H van der Burg, M J Visseren, R M Brandt, W M Kast and C J Melief
    J Immunol May 1, 1996, 156 (9) 3308-3314;
  • You have accessRestricted access
    Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis.
    P O Flores-Villanueva, X X Zheng, T B Strom and M J Stadecker
    J Immunol May 1, 1996, 156 (9) 3315-3320;
  • You have accessRestricted access
    Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location.
    J Hess, C Ladel, D Miko and S H Kaufmann
    J Immunol May 1, 1996, 156 (9) 3321-3326;
  • You have accessRestricted access
    CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.
    P Lu, J F Urban, X D Zhou, S J Chen, K Madden, M Moorman, H Nguyen, S C Morris, F D Finkelman and W C Gause
    J Immunol May 1, 1996, 156 (9) 3327-3333;
  • You have accessRestricted access
    Antibodies to an autostimulatory growth factor (IL-2) or its receptor induce death of leukemogenic cells.
    P C Orban and J W Schrader
    J Immunol May 1, 1996, 156 (9) 3334-3341;
  • You have accessRestricted access
    Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    M Pope, S W Chung, T Mosmann, J L Leibowitz, R M Gorczynski and G A Levy
    J Immunol May 1, 1996, 156 (9) 3342-3349;
  • You have accessRestricted access
    Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen.
    X Qiu, P Schroeder and D Bridon
    J Immunol May 1, 1996, 156 (9) 3350-3356;
  • You have accessRestricted access
    IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
    J B Rao, R S Chamberlain, V Bronte, M W Carroll, K R Irvine, B Moss, S A Rosenberg and N P Restifo
    J Immunol May 1, 1996, 156 (9) 3357-3365;
  • You have accessRestricted access
    Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.
    K Takeda, S Seki, K Ogasawara, R Anzai, W Hashimoto, K Sugiura, M Takahashi, M Satoh and K Kumagai
    J Immunol May 1, 1996, 156 (9) 3366-3373;
  • You have accessRestricted access
    MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    K L White, H L Snyder and U Krzych
    J Immunol May 1, 1996, 156 (9) 3374-3381;
  • You have accessRestricted access
    Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas.
    I R Williams, R J Ort, D Daley, L Manning, T Karaoli, R L Barnhill and T S Kupper
    J Immunol May 1, 1996, 156 (9) 3382-3388;
  • You have accessRestricted access
    Chemotactic factors stimulate CD18-dependent canine neutrophil adherence and motility on lung fibroblasts.
    A R Burns, S I Simon, G L Kukielka, J L Rowen, H Lu, L H Mendoza, E S Brown, M L Entman and C W Smith
    J Immunol May 1, 1996, 156 (9) 3389-3401;
  • You have accessRestricted access
    Human skeletal myoblasts spontaneously activate allogeneic complement but are resistant to killing.
    P Gasque, B P Morgan, J Legoedec, P Chan and M Fontaine
    J Immunol May 1, 1996, 156 (9) 3402-3411;
  • You have accessRestricted access
    Peptides derived from C-reactive protein inhibit neutrophil alveolitis.
    R M Heuertz, N Ahmed and R O Webster
    J Immunol May 1, 1996, 156 (9) 3412-3417;
  • You have accessRestricted access
    Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines.
    A Müller, P J Rice, H E Ensley, P S Coogan, J H Kalbfleish, J L Kelley, E J Love, C A Portera, T Ha, I W Browder and D L Williams
    J Immunol May 1, 1996, 156 (9) 3418-3425;
  • You have accessRestricted access
    Pathologic leukocyte infiltration of the rabbit aorta confers a vasomotor effect to chemotactic peptides through cyclooxygenase-derived metabolites.
    E Petitclerc, L Levesque, J H Grose, P E Poubelle and F Marceau
    J Immunol May 1, 1996, 156 (9) 3426-3434;
  • You have accessRestricted access
    Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors.
    F G Sajjadi, K Takabayashi, A C Foster, R C Domingo and G S Firestein
    J Immunol May 1, 1996, 156 (9) 3435-3442;
  • You have accessRestricted access
    Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit.
    Y Shimizu, L K Ashman, Z Du and L B Schwartz
    J Immunol May 1, 1996, 156 (9) 3443-3449;
  • You have accessRestricted access
    Heat shock mimics glucocorticoid effects on IFN-gamma-induced Fc gamma RI and Ia messenger RNA expression in mouse peritoneal macrophages.
    J Sivo, J M Harmon and S N Vogel
    J Immunol May 1, 1996, 156 (9) 3450-3454;
  • You have accessRestricted access
    A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis.
    T Takabayashi, E Vannier, B D Clark, N H Margolis, C A Dinarello, J F Burke and J A Gelfand
    J Immunol May 1, 1996, 156 (9) 3455-3460;
  • You have accessRestricted access
    Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes.
    Z Toossi, C S Hirsch, B D Hamilton, C K Knuth, M A Friedlander and E A Rich
    J Immunol May 1, 1996, 156 (9) 3461-3468;
  • You have accessRestricted access
    Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway.
    H D Um, J M Orenstein and S M Wahl
    J Immunol May 1, 1996, 156 (9) 3469-3477;
  • You have accessRestricted access
    Persistence of dominant T cell clones in synovial tissues during rheumatoid arthritis.
    A Alam, N Lambert, J Lulé, H Coppin, B Mazières, C de Préval and A Cantagrel
    J Immunol May 1, 1996, 156 (9) 3480-3485;
  • You have accessRestricted access
    Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers.
    B J Coventry, S C Weeks, S E Heckford, P J Sykes, J Bradley and J M Skinner
    J Immunol May 1, 1996, 156 (9) 3486-3492;
  • You have accessRestricted access
    Restricted V beta usage by T cells infiltrating rejecting human lung allografts.
    L A DeBruyne, J P Lynch 3rd, L A Baker, R Florn, G M Deeb, R I Whyte and D K Bishop
    J Immunol May 1, 1996, 156 (9) 3493-3500;
  • You have accessRestricted access
    Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells.
    D Goletti, A L Kinter, E C Hardy, G Poli and A S Fauci
    J Immunol May 1, 1996, 156 (9) 3501-3508;
  • You have accessRestricted access
    Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.
    M L Gougeon, H Lecoeur, A Dulioust, M G Enouf, M Crouvoiser, C Goujard, T Debord and L Montagnier
    J Immunol May 1, 1996, 156 (9) 3509-3520;
  • You have accessRestricted access
    Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
    K C Herold, V Vezys, Q Sun, D Viktora, E Seung, S Reiner and D R Brown
    J Immunol May 1, 1996, 156 (9) 3521-3527;
  • You have accessRestricted access
    Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis.
    S A Huber and M W Cunningham
    J Immunol May 1, 1996, 156 (9) 3528-3534;
  • You have accessRestricted access
    Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.
    Y H Lou, M F McElveen, K M Garza and K S Tung
    J Immunol May 1, 1996, 156 (9) 3535-3540;
  • You have accessRestricted access
    Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated.
    A M Madec, F Rousset, S Ho, F Robert, C Thivolet, J Orgiazzi and S Lebecque
    J Immunol May 1, 1996, 156 (9) 3541-3549;
  • You have accessRestricted access
    Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats.
    T Murohara, J A Delyani, S M Albelda and A M Lefer
    J Immunol May 1, 1996, 156 (9) 3550-3557;
  • You have accessRestricted access
    Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy.
    K Otani, I Nita, W Macaulay, H I Georgescu, P D Robbins and C H Evans
    J Immunol May 1, 1996, 156 (9) 3558-3562;
  • You have accessRestricted access
    Human CD4-internal antigen anti-idiotypic monoclonal antibody: induction of a CD4-specific response in humans.
    F Perosa, M Scudeletti, M A Imro, F Dammacco and F Indiveri
    J Immunol May 1, 1996, 156 (9) 3563-3569;
  • You have accessRestricted access
    Rheumatoid factor idiotypic and antigenic specificity is strongly influenced by the light chain VJ junction.
    M Zhang, D Spey, S Ackerman, A Majid and A Davidson
    J Immunol May 1, 1996, 156 (9) 3570-3575;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 156, Issue 9
1 May 1996
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • CUTTING EDGE
  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606